CAPPED BONUS CERTIFICATE - SARTORIUS STEDIM BIO Stock

Certificat

7G93S

FRSGE001PY90

Market Closed - Euronext Paris 12:30:01 2024-05-27 EDT
199.8 EUR -2.35% Intraday chart for CAPPED BONUS CERTIFICATE - SARTORIUS STEDIM BIO
Current month-9.81%
1 month-12.03%
Date Price Change
24-05-27 199.8 -2.35%
24-05-24 204.6 -0.99%
24-05-23 206.6 -1.70%
24-05-22 210.2 -0.72%
24-05-21 211.8 -0.99%

Real-time Euronext Paris

Last update May 27, 2024 at 12:30 pm

More quotes

Static data

Product typeBonus- und Teilschutz-Zertifikate
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer Société Générale Société Générale
7G93S
ISINFRSGE001PY90
Date issued 2024-04-15
Strike 300
Maturity 2024-12-20 (207 Days)
Parity 1 : 1
Emission price 259.9
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 261.6
Lowest since issue 198
Spread 2.89
Spread %1.44%

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
187.6 EUR
Average target price
248.8 EUR
Spread / Average Target
+32.61%
Consensus
  1. Stock Market
  2. Certificates
  3. 7G93S Certificat